Keywords: Takeda, Edarbi, European Commission, Hypertension

Takeda’s Edarbi Oked in EU

Article | 12 December 2011

Print This

In another piece of positive news for Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502), the company said last week ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in